TWiV 790: COVID-19 clinical update #74 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #74, Daniel Griffin covers infections in vaccinated individuals, expansion of Regeneron monoclonal antibody cocktail for prophylaxis, neutralization of variants by antibodies produced by infection or vaccination, longer hospital stays associated with remdesivir treatment, and post-acute sequelae of infection and impact on quality of life 1-6 months after illness.</p> <p>Hosts: <a href="http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href= "http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></p> <p>Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></p> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li>Outbreak in <a href= "https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e2.htm">Barnstable County, MA</a> (MMWR)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2021.07.28.21261295v1">Kinetics</a> of delta variant infections (medRxiv)</li> <li>Prophlaxis with Regeneron mAbs (<a href= "https://newsroom.regeneron.com/news-releases/news-release-details/fda-expands-authorized-use-regen-covtm-casirivimab-and-imdevimab">Regeneron</a>)</li> <li><a href= "https://www.nejm.org/doi/full/10.1056/NEJMoa2109682">Subcutaneous mAbs</a> to prevent COVID-19 (NEJM)</li> <li><a href= "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab646/6327511"> Variant neutralization</a> by infection or vaccine antibodies (Clin Inf Dis)</li> <li>Remdesivir associated with <a href= "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781959">longer hospital stays</a> (JAMA)</li> <li>Post-acute <a href= "https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/of